Skip to main content
. 2024 Feb 1;22:18. doi: 10.1186/s12958-024-01191-0

Table 2.

Characteristics and findings of hysteroscopy in included RCTs

Author, publication year Abnormal
hysteroscopy
Etiology of unsuspected lesions1 Instrument Anesthesia/
Sedation
Timing of procedure/subsequent ART
Demirol et al. (2004) 26.7%

EM polyps 15.7%

IUA 8.5%

Cervix stenosis 2.3%

5 mm diameter with 5 Fr working channel, 30° view (Bettocchi) Midazolam 0.1 mg/kg IV when needed Early follicular phase/NA
Raju et al. (2006) 38.0%

EM polyps 12.8%

Abn Cervix 12%

IUA 4.8%

EM hyperplasia 4.8%

Fibroids 0.4%

Anomalies2 3.2%

5 mm diameter with 5 Fr working channel, 30° view (Krishna) Midazolam 0.1 mg/kg IV when needed NA/NA
Shawki et al. (2012) 33.4%

EM polyps 10.8%

IUA 3.8%

Fibroids 3.8%

Endometritis 1.9%

Anomalies2 0.9%

EM hyperplasia 2.8%

3.5 mm diameter, 0° view (Versascope, Gynecare, Ethicon, Sommerville, NJ, USA) None NA/NA
Elsetohy et al. (2014) 43.3%

EM polyps 13.4%

Anomalies2 10.4%

Fibroids 7.2%

IUA 6.2%

4.3 mm diameter with 5 Fr working channel, 30° view NA Early to mid-follicular phase/Start ICSI cycle within 3 months
Alleyassin et al. (2015) 22.7%

Anomalies2 13.6%

EM polyps 5.4%

IUA 0.9%

EM hyperplasia 1.8%

4 mm diameter rigid hysteroscopy, 30°view None Mid-luteal phase/Start ICSI next cycle
Smit et al. (2016) 13.0%

EM polyps 9.5%

Anomalies2 2.3%

Fibroids 1.3%

IUA 1%

5 mm diameter with 5 Fr working channel, 30° view Paracervical block when needed Early to mid-follicular phase/Start ICSI cycle within 3 months
El-Toukhy et al. (2016) 26.0%

Anomalies2 8%

Cx stenosis 4%

EM polyps 3%3

IUA 0.9%

2.9 mm diameter rigid hysteroscopy, 30° view (TROPHYscope; Karl Storz, Tuttlingen) None Follicular phase/Started IVF in the following month
Abid et al. (2021) 31.0%

IUA 13%

EM polyps 8.3%

Endometritis 8.3%

Fibroids 1.2%

2.9 mm diameter (26,120 BA STORZ) Analgesic treatment level 2 (Paracetamol/Codeine 500 mg/30 mg) 1 h before the procedure Mid-follicular phase/Started IVF in the following month
Pounikar et al. (2022) 40.0% NA NA NA NA/Started IVF in the following month
Ghasemi et al. (2022) NA NA 5 Fr working channel, 30° view4 NA Early to mid-follicular phase/NA

ART, artificial reproductive treatment; EM, endometrial; IUA, intrauterine adhesion; Cx, cervix; IV, intravenous; NA, not available; ICSI, intracytoplasmic sperm injection

1 The percentage was calculated based on the number of patients who received hysteroscopy

2 The anomalies include septate, arcuate, or bicornuate uterus

3 The incidence included 1% micropolyps

4 The study did not report the diameter of the hysteroscopy